Heimdall Insights

Global Viral Vector Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Viral Vector Market was valued at $6.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 20.5% CAGR, to an estimated market size of $16.5 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global viral vector market encompasses the manufacturing services, infrastructure, and biological tools used to produce modified viruses – such as Adeno-associated virus (AAV), Lentivirus, and Adenovirus – designed to deliver therapeutic genetic material into target cells. The scope includes both in-house production by biopharmaceutical companies and outsourced services provided by Contract Development and Manufacturing Organizations (CDMOs) for applications in gene therapy, cell therapy, and vaccine development.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Viral Vector Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Adeno-associated Virus (AAV)
  • Lentiviral Vectors
  • Adenoviral Vectors
  • Other Vectors (Retroviral, Sendai, etc.)